Monoclonal gammopathy of undetermined significance and smoldering myeloma. Multiple myeloma early detection, diagnosis, and staging 1. Hemoglobin value 10 gdl serum calcium value normal or multiple myeloma mm arises from postgerminal b cells in the lymph node, with immunoglobulin ig gene rearrangement, extensive somatic hypermutation, and class switching of immunoglobulin heavy chain igh genes, suggesting that the malignant plasma cells have undergone antigen selection. Multiple myeloma, also called plasma cell myeloma or myelomatosis, malignant proliferation of cells within the bone marrow that usually occurs during middle age or later and.
Oslo university hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the. Jatin shah, md, explains that there is no clear reason for why patients develop multiple myeloma, and so theres no clear risk factor. Request pdf epidemiology and pathophysiology of multiple myeloma multiple myeloma is a hematological malignancy characterized by the accumulation of malignant plasma cells in the bone. Multiple myeloma hematology and oncology merck manuals. Multiple myeloma mm is a fatal, malignant bcell neoplasm characterized by uncontrolled, destructive growth of mutated plasma cells within the bone marrow. Multiple myeloma mm is a b cell malignancy characterized by enhanced bone loss commonly associated with diffuse osteopenia, focal lytic lesions, pathologic fractures, hypercalcemia. Common manifestations include lytic lesions in bones causing pain. Please use one of the following formats to cite this article in your essay, paper or report. Multiple myeloma early detection, diagnosis, and staging. Plasma cells help you fight infections by making antibodies that recognize and attack germs. Apr 18, 20 hideshima t, chauhan d, schlossman r, richardson p, anderson kc. Scientists still do not know exactly what causes most cases of multiple myeloma.
This activity is accompanied by suppressed osteoblast. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. Myeloma is called multiple because it frequently involves multiple areas in the. The bone marrow produces red blood cells, which carry oxygen throughout. The patient handbook focuses on the questions and decisions that a newly diagnosed patient faces. What is the pathophysiology of multiple myeloma mm. Multiple myeloma mm is a plasma cell malignancy characterized by a high capacity to induce osteolytic bone lesions. New insights into the pathophysiology of multiple myeloma. Understanding the pathogenesis of myeloma bone disease has allowed us to identify novel targets for treating the disease.
Consensus recommendations for risk stratification in multiple myeloma. Multiple myeloma is a hematological malignancy characterized by the accumulation of malignant plasma cells in the bone marrow and in the majority of cases, findings of monoclonal immunoglobulins in the blood. Multiple myeloma mm is characterised by the accumulation of clonal, malignant plasma cells in the bone marrow. Pdl1pd1 pathway in the pathophysiology of multiple myeloma. Bone destruction is a hallmark of multiple myeloma mm. Multiple myeloma epidemiology and patient geographic distribution in canada. They generally express cd8 syndecan 1, cd38, and other heterogeneous immunophenotypic markers. Monoclonal gammopathy of undetermined significance and. Radiation may be a factor in some cases although there is no association with therapeutic radiation. Pdf multiple myeloma is divided into two distinct genetic subtypes based on chromosome content. This activity is accompanied by suppressed osteoblast differentiation and activity, resulting in severely impaired bone formation and development of devastating osteolytic lesions. Plasma cells from multiple myeloma mm patients expressed higher levels of pdl1 compared with.
Pathophysiology the pathological and clinical features of myeloma are due to. Multiple myeloma mm, also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. As it progresses, bone pain, bleeding, frequent infections, and anemia may occur. Multiple myeloma is a common hematologic malignancy characterized by recurrent relapsing disease course requiring use of various therapies. More than 80% of mm patients suffer from destructive bony. However, they have made progress in understanding how certain changes. Request pdf epidemiology and pathophysiology of multiple myeloma multiple myeloma is a hematological malignancy characterized by the accumulation of malignant plasma cells in the bone marrow.
Multiple myeloma mm, also known as plasma cell myeloma and simple myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Multiple myeloma is a cancer that develops in the bone marrow, the spongy tissue found in the center of most bones. Myeloma is called multiple because it frequently involves multiple areas in the body. Multiple myeloma is a plasma cell malignancy characterized by the frequent development of osteolytic bone lesions. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. Myelomas are slightly more common in males than in females and can affect any of the marrowcontaining bones, such as the skull, the flat. Myeloma is a cancer of the plasma cells in the bone marrow. The multiple myelomainduced bone destruction is a result of the increased activity of osteoclasts that occurs adjacent to multiple myeloma cells. A solitary bone plasmacytoma sbp arises from the plasma cells located in the bone marrow, whereas an extramedullary plasmacytoma emp is.
Multiple myeloma accounts for approximately 10% of hematologic malignancies. Multiple myeloma is a hematological malignancy characterized by the accumulation of malignant plasma cells in the bone marrow and in the majority of cases, findings of. Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Multiple myeloma mm is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an. The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma. New insights into pathophysiology and epidemiology ola landgren 1 multiple myeloma section, medical oncology. Patients endure severe bone pain, pathologic fractures, hypercalcemia, and a markedly decreased quality of life. Multiple myeloma always develops from mgus monoclonal gammopathy of undetermined significance. We hope that the information will be helpful to both healthcare professionals and patients.
Multiple myeloma is a malignant disease characterized by plasmacytosis, paraprotein production, bone lesions, hypercalcemia, susceptibility to infections, and renal impairment. Learn about the risk factors for multiple myeloma and what you might be able to do to help lower your risk. First described in 1848, mm is characterized by a proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein m protein. Multiple myeloma mm arises from postgerminal b cells in the lymph node, with immunoglobulin ig gene rearrangement, extensive somatic hypermutation, and class switching of immunoglobulin heavy chain igh genes, suggesting that the malignant plasma cells have undergone antigen selection. Plasma cells from multiple myeloma mm patients expressed higher levels of pdl1 compared with healthy volunteers and monoclonal gammopathy of undetermined significance mgus patients, and its expression is significantly upregulated in relapsedrefractory patients. Management of newly diagnosed symptomatic multiple myeloma. Feb 27, 2019 please use one of the following formats to cite this article in your essay, paper or report. Pathophysiology and diagnosis of multiple myeloma jatin shah, md, explains that there is no clear reason for why patients develop multiple myeloma, and so theres no clear risk factor.
Jun 12, 2019 multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. Recently the biologic mechanism involved in the imbalance between osteoclast activation and osteoblast inhibition induced by multiple myeloma cells has begun to be clarified. Pdf myeloma bone disease mbd is a devastating complication of multiple myeloma mm. Pdl1 expressed on tumor cells contributes to disease progression with evasion from tumor immunity. Mm patients develop osteolytic bone lesions that can cause pathologic fractures and. Common manifestations include lytic lesions in bones causing pain, andor fractures, renal insufficiency, hypercalcemia, anemia, and recurrent infections. In 2015, an estimated 28,850 new cases of multiple. Pathophysiology of multiple myeloma bone disease pubmed. Jun 25, 20 classification stage i low cell mass 600 billion myelomacellsall of the following. Cardiovascular complications associated with multiple. Myeloma bone disease is responsible for some of the most devastating complications of the disease.
Multiple myeloma mm is a plasma cell dyscrasia characterized by terminally differentiated plasma cells, infiltration of the bone marrow by plasma cells, and the presence of a monoclonal immunoglobulin or immunoglobulin fragment in the serum andor urine. The multiple myeloma induced bone destruction is a result of the increased activity of osteoclasts that occurs adjacent to multiple myeloma cells. For understanding of the pathophysiology of multiple myeloma, features of the malignant clone and changes induced by the bonemarrow microenvironment are equally important. Among the earliest genetic events are translocations of the immunoglobulin heavychain gene. A solitary bone plasmacytoma sbp arises from the plasma cells located in the bone marrow, whereas an extramedullary plasmacytoma. Abnormal antibody fragments are produced in multiple myeloma and are deposited in various organs, such as the kidneys. Multiple myeloma plasma cells, which originate from postfollicular b cells, are characterised by complex chromosomal aberrations. The risk that mgus progresses into malignant disease is about 1% annually. Multiple myeloma symptoms, diagnosis and treatment bmj. What is the pathophysiology of solitary plasmacytoma. Treatment for myeloma bone disease clinical cancer research. The bone marrow produces red blood cells, which carry oxygen throughout the body. Apr 23, 2020 multiple myeloma, also called plasma cell myeloma or myelomatosis, malignant proliferation of cells within the bone marrow that usually occurs during middle age or later and increases in occurrence with age.
Review pathophysiology of multiple myeloma folliclecentre b cells are the likely cell of origin in patients with multiple myeloma, plasma cells show characteristic features of longlived bonemarrow cells. Pathophysiology of multiple myeloma bone disease sciencedirect. Multiple myeloma mm is the most frequent cancer to involve the skeleton with 8090% of patients developing bone lesions during their disease course. Epidemiology and pathophysiology multiple myeloma accounts for 1. Multiple myeloma mm is a bcell malignancy characterized by the clonal proliferation of malignant plasma cells in the bone marrow. There are three major forms of renal damage in patients with multiple myeloma. Multiple myeloma mm is a plasma cell dyscrasia characterized by malignant proliferation of monoclonal plasma cells in the bone marrow. Epidemiology and pathophysiology of multiple myeloma. The imfs patient handbook is designed to help you to understand multiple myeloma which we refer to simply as myeloma. Get an overview of multiple myeloma and the latest key statistics in the us. The underlying pathophysiologic phenomena of the clinical features include suppression of humoral and cellmediated immunity, elevation of il6, abnormalities of the bone marrow microenvironment, and increased. Scribd is the worlds largest social reading and publishing site.
321 726 978 322 480 967 540 851 1144 1141 1525 901 90 923 1117 686 306 259 1519 1308 1609 1553 1179 251 1307 361 1256 365 207 1119 1123 894 1528 195 1002 1386 654 1209 707 501 676 884 499 388